![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2023\/03\/018-cover-734x1024.jpg\")
<\/figure>\n\n\n\nTheory and practice of intellectual property
\u2116 2 \/ 2024<\/p>\n\n\n\n
ISSN (Print) 2308-0361
ISSN (Online) 2519-2744<\/p>\n\n\n\n
![\"\"](\"https:\/\/test.inprojournal.org\/wp-content\/uploads\/2023\/01\/free-icon-pdf-201153.png\"){kind=icon}
PDF (Ukrainian)<\/a><\/div>\n<\/div>\n\n\n\nDOI: https:\/\/doi.org\/10.33731\/22024.305605<\/a><\/p>\n\n\n\n Submitted 2024-03-21 <\/p>\n\n\n\n <\/p>\n<\/div>\n\n\n\n The evolution of intellectual property policy in the healthcare: consequences of the pandemic and wartime<\/strong><\/p>\n\n\n\n Oksana Kashyntseva<\/strong> Olha Omelchenko<\/strong> <\/p>\n\n\n\n Abstract The WTO waiver decision of TRIPS on COVID-19 vaccines (the use of a patented subject matter required for the production and supply of COVID-19 vaccines without the consent of the right holder to the extent necessary to overcome the COVID-19 pandemic, in accordance with the provisions of Article 31, TRIPS Agreement) has played an unprecedented role in ensuring access to vaccines for people in countries with different levels of development. However, there is a need to extend the WTO decision to cover the COVID-19 diagnostic and therapeutic products. So far, this issue is being under discussion, which agenda is the unequal access of countries with different levels of development to COVID-19 vaccines, diagnostics, and therapeutics.<\/p>\n\n\n\n The COVID-19 pandemic has \u00abexposed the confrontation\u00bb between the protection of intellectual property rights and ensuring fundamental human rights: the right to life and the right to health.<\/p>\n\n\n\n The relevance of overcoming the barriers created by intellectual property rights in the context of access to medicines for Ukraine has become even more urgent due to the full-scale invasion of Ukraine by the Russian Federation and the resulting humanitarian crisis in the national healthcare system. That is why it is important for Ukraine to use all available remedies to ensure access to medical treatment. Such remedies are provided for in the TRIPS Agreement, in particular, Article 31 and Article 73.<\/p>\n\n\n\n When deciding on compulsory licensing of intellectual property rights in the area of medicine and pharmacy, it is necessary to proceed from the fundamental principle of law \u2014 the principle of humanism, which actually determines the value of a human being and its right to happiness. The authors insist on the inadmissibility of the absolutization of intellectual property rights.<\/p>\n\n\n\n Keywords: <\/strong>intellectual property rights, human rights, access to medicines, EU legislation<\/p>\n\n\n\n References<\/strong><\/p>\n\n\n\n WHO COVID-19 dashboard. Lauterbach wants to prepare the healthcare system for wars. \u041f\u0440\u043e\u0454\u043a\u0442 \u00abTIPSTER: \u0422\u043e\u0440\u0433\u0456\u0432\u043b\u044f, \u043f\u0456\u0434\u0442\u0440\u0438\u043c\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u0442\u0430 \u0442\u0435\u0445\u043d\u0456\u0447\u043d\u0435 \u0440\u0435\u0433\u0443\u043b\u044e\u0432\u0430\u043d\u043d\u044f\u00bb. WT\/MIN(22)\/W\/15\/Rev.2. The TRIPS Intellectual Property Waiver Proposal: Creating the Right Incentives in Patent Law and Politics to end the COVID-19 Pandemic. [S. Thambisetty, A. McMahon, L. McDonagh at al.] LSE Law, Society and Economy Working Papers. 2021. \u2116 06. Rutschman A. S. Ministerial Decision on the Trips Agreement (WTO). Cambridge University Press on behalf of The American Society of International Law. \u0425\u0430\u0440\u0438\u0442\u043e\u043d\u043e\u0432\u0430 \u041e. \u0406. COVID19 \u0456 \u043f\u0440\u0430\u0432\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. \u0417\u0430\u043a\u0430\u0440\u043f\u0430\u0442\u0441\u044c\u043a\u0456 \u043f\u0440\u0430\u0432\u043e\u0432\u0456 \u0447\u0438\u0442\u0430\u043d\u043d\u044f. \u0420\u043e\u0437\u0432\u0438\u0442\u043e\u043a \u043f\u0440\u0430\u0432\u043e\u0432\u043e\u0457 \u0441\u0438\u0441\u0442\u0435\u043c\u0438 \u0442\u0430 \u0454\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0430 \u0456\u043d\u0442\u0435\u0433\u0440\u0430\u0446\u0456\u044f \u0423\u043a\u0440\u0430\u0457\u043d\u0438: \u043c\u0430\u0442\u0435\u0440\u0456\u0430\u043b\u0438 \u0425\u0406\u0406\u0406 \u041c\u0456\u0436\u043d\u0430\u0440\u043e\u0434\u043d\u043e\u0457 \u043d\u0430\u0443\u043a\u043e\u0432\u043e-\u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u043e\u0457 \u043a\u043e\u043d\u0444\u0435\u0440\u0435\u043d\u0446\u0456\u0457 (\u043c. \u0423\u0436\u0433\u043e\u0440\u043e\u0434, 22-28 \u0442\u0440\u0430\u0432\u043d\u044f 2021 \u0440\u043e\u043a\u0443). \u0423\u0436\u0433\u043e\u0440\u043e\u0434, 2021. \u0421. 14-19.<\/p>\n\n\n\n Gold R. \u0415. What the COVID-19 pandemic revealed about intellectual property. Nature Biotechnology. 2022. 2023 Progress report on the Global Action Plan for Healthy Lives and Well-being for All What worked? What didn\u2019t? What\u2019s next? \u041a\u0430\u0448\u0438\u043d\u0446\u0435\u0432\u0430 \u041e., \u0406\u043e\u043b\u043a\u0456\u043d \u042f. \u0414\u043e\u0442\u0440\u0438\u043c\u0430\u043d\u043d\u044f \u0431\u0430\u043b\u0430\u043d\u0441\u0443 \u0456\u043d\u0442\u0435\u0440\u0435\u0441\u0456\u0432 \u0441\u0443\u0441\u043f\u0456\u043b\u044c\u0441\u0442\u0432\u0430 \u0442\u0430 \u0456\u043d\u0442\u0435\u0440\u0435\u0441\u0456\u0432 \u0441\u0443\u0431\u2019\u0454\u043a\u0442\u0456\u0432 \u043f\u0430\u0442\u0435\u043d\u0442\u043d\u0438\u0445 \u043f\u0440\u0430\u0432 \u043f\u0440\u0438 \u043a\u043e\u0434\u0438\u0444\u0456\u043a\u0430\u0446\u0456\u0457 \u0437\u0430\u043a\u043e\u043d\u043e\u0434\u0430\u0432\u0441\u0442\u0432\u0430 \u0443 \u0441\u0444\u0435\u0440\u0456 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. \u0422\u0435\u043e\u0440\u0456\u044f \u0456 \u043f\u0440\u0430\u043a\u0442\u0438\u043a\u0430 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456. 2021. \u2116 6. \u0421. 87-93. Council for Trade-Related Aspects of Intellectual Property Rights – Minutes of meeting – Held in the Centre William Rappard on 16 – 17 March 2023 \u2013 Addendum. WHO chief declares end to COVID-19 as a global health emergency. Compulsory licensing of patents for crisis management. European Parliament Challenged to Enable Non-EU Countries to Benefit from Medical Products Made Under Compulsory Licences. Abu Dhabi Ministerial Declaration. \u0423\u0433\u043e\u0434\u0430 \u043f\u0440\u043e \u0442\u043e\u0440\u0433\u043e\u0432\u0435\u043b\u044c\u043d\u0456 \u0430\u0441\u043f\u0435\u043a\u0442\u0438 \u043f\u0440\u0430\u0432 \u0456\u043d\u0442\u0435\u043b\u0435\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u043e\u0457 \u0432\u043b\u0430\u0441\u043d\u043e\u0441\u0442\u0456 \u0432\u0456\u0434 15 \u043a\u0432\u0456\u0442\u043d\u044f 1994 \u0440. Gurgula \u041e. Saving Ukrainian Lives during the Russian War: Ukraine Must Waive IP Rights under Article 73 TRIPS to Provide Access to Essential Medicines (April 12, 2022). Human rights and the COVID-19 pandemic: a retrospective and prospective analysis [Gostin O. Lawrence, Friedman A. Eric, Hossain Sara at al.] The Lancet. 2023. Vol. 401. P. 154-168. Estimated total costs associated with welcoming and supporting Ukrainian refugees in the European OECD countries as of October 2022, by type. \u042f\u043a \u0432\u0456\u0439\u043d\u0430 \u043f\u043e\u0433\u0456\u0440\u0448\u0443\u0454 \u0435\u043f\u0456\u0434\u0435\u043c\u0456\u0447\u043d\u0443 \u0441\u0438\u0442\u0443\u0430\u0446\u0456\u044e \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456. \u0425\u043e\u043b\u0435\u0440\u0430, \u0433\u0435\u043f\u0430\u0442\u0438\u0442, \u0434\u0438\u0437\u0435\u043d\u0442\u0435\u0440\u0456\u044f: \u0441\u043f\u0430\u043b\u0430\u0445 \u044f\u043a\u0438\u0445 \u0445\u0432\u043e\u0440\u043e\u0431 \u0437\u0430\u0433\u0440\u043e\u0436\u0443\u0454 \u0447\u0435\u0440\u0435\u0437 \u0437\u0430\u0442\u043e\u043f\u043b\u0435\u043d\u043d\u044f \u0425\u0435\u0440\u0441\u043e\u043d\u0449\u0438\u043d\u0438?
Accepted 2024-03-30
Published 2024-06-04<\/p>\n\n\n\n![\"\"](\"https:\/\/inprojournal.org\/wp-content\/uploads\/2025\/11\/CC-2.png\")
<\/figure>\n\n\n\n
Ph.D. (Law), Associate Professor, Head of the Department of Intellectual Property Rights and Human Rights in Public Health of the Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine
Ukraine
https:\/\/orcid.org\/0000-0002-2598-5614<\/a><\/p>\n\n\n\n
Ph.D. (Law), researcher at the Department for Research on Intellectual Property Rights and Human Rights in Healthcare of the Intellectual Property Scientific Research Institute of the National Academy of Legal Sciences of Ukraine
Ukraine
https:\/\/orcid.org\/0000-0002-3265-205X<\/a><\/p>\n\n\n\n
<\/strong>The article studies the trends in the formation of intellectual property policy in the area of healthcare at the level of the World Trade Organization in connection with the global healthcare crisis caused by COVID-19. It analyzes the relevant issues of waiver from IP rights to medicine and pharmacy objects in accordance with the TRIPS Agreement to ensure access to COVID-19 diagnostic and therapeutic products, given the need to guarantee the fundamental human rights to life and health.<\/p>\n\n\n\n
https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c<\/a><\/p>\n\n\n\n
https:\/\/www.tagesschau.de\/inland\/lauterbach-militaerkonflikt-gesundheitswesen-100.html<\/a><\/p>\n\n\n\n
https:\/\/fsr.org.ua\/page\/proyekt-tipster-torgivlya-pidtrymka-intelektualnoyi-vlasnosti-ta-tehnichne-regulyuvannya<\/a><\/p>\n\n\n\n
https:\/\/docs.wto.org\/dol2fe\/Pages\/SS\/directdoc.aspx?filename=q:\/WT\/MIN22\/W15R2.pdf&Open=True<\/a><\/p>\n\n\n\n
https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=3851737<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.1017\/ilm.2022.47<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.1038\/s41587-022-01485-x<\/a><\/p>\n\n\n\n
https:\/\/iris.who.int\/bitstream\/handle\/10665\/367422\/9789240073371-eng.pdf?sequence=1<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.33731\/62021.249080<\/a><\/p>\n\n\n\n
https:\/\/docs.wto.org\/dol2fe\/Pages\/FE_Search\/FE_S_S006.aspx?Query=(%20@Symbol=%20ip\/c\/m\/*)&Language=ENGLISH&Context=FomerScriptedSearch&languageUIChanged=true<\/a><\/p>\n\n\n\n
https:\/\/news.un.org\/en\/story\/2023\/05\/1136367<\/a><\/p>\n\n\n\n
https:\/\/www.europarl.europa.eu\/thinktank\/en\/document\/EPRS_BRI(2024)757634<\/a><\/p>\n\n\n\n
https:\/\/healthpolicy-watch.news\/european-parliament-challenged-to-enable-non-eu-countries-to-benefit-from-medical-products-made-under-compulsory-licences\/<\/a><\/p>\n\n\n\n
https:\/\/docs.wto.org\/dol2fe\/Pages\/SS\/directdoc.aspx?filename=q:\/WT\/MIN24\/W12R1.pdf<\/a><\/p>\n\n\n\n
https:\/\/zakon.rada.gov.ua\/laws\/show\/981_018<\/a><\/p>\n\n\n\n
http:\/\/dx.doi.org\/10.2139\/ssrn.4082247<\/a><\/p>\n\n\n\n
https:\/\/doi.org\/10.1016\/S0140-6736(22)01278-8<\/a><\/p>\n\n\n\n
https:\/\/www.statista.com\/statistics\/1346570\/costs-of-receiving-ukrainian-refugees-by-country\/<\/a><\/p>\n\n\n\n
https:\/\/www.dw.com\/uk\/tuberkuloz-vil-ta-kholera-yaki-ryzyky-nese-viina-dlia-zdorovia-ukraintsiv\/a-62092825<\/a><\/p>\n\n\n\n
https:\/\/www.radiosvoboda.org\/a\/novyny-pryazovya-potop-khersonshchyna-kholera-hepatyt-spalakh-epidemiy\/32459344.html<\/a><\/p>\n\n\n\n